ATED Therapeutics Ltd. Finalist in Health Products Category of Fast Company’s 2024 World Changing Ideas Awards

TEL AVIV, Israel & GREENWICH, Conn.--()--The winners and finalists of Fast Company’s 2024 World Changing Ideas Awards were announced today, highlighting fresh sustainability initiatives, cutting-edge AI developments, ambitious pursuits of social equity, and other creative projects that are helping mold the world.

ATED Therapeutics, Ltd. was named a Finalist in the Health Products Category for its development of a rapid (24 hr.), PCR, tRNA (transfer RNA) blood test for Parkinson’s Disease. The test was developed by Professor Hermona Soreq at Hebrew University in Jerusalem and licensed from Yissum. The test can identify Parkinson’s Disease at its earliest stage, its progression, as well as the effectiveness of deep brain stimulation (DBS).

“Being named a Finalist in Fast Company’s World Changing Ideas Awards is a significant validation of ATED’s mission of developing new diagnostics and therapeutic drugs to treat Parkinson’s Disease,” said CEO Jeff R. Swarz, Ph.D. “It is a confirmation of the groundbreaking work of Dr. Soreq and her team of dedicated scientists.”

This year’s World Changing Ideas Awards showcase 50 winners, 127 finalists, and 172 honorable mentions—with health, education, energy, and AI among the most popular categories. A panel of Fast Company editors and reporters selected winners from a pool of more than 1,300 entries across climate, social justice, wellness, politics, technology, corporate social responsibility, and more.

Fast Company’s Spring 2024 issue (on newsstands May 21, 2024) will unveil some of the world’s most creative minds and pioneering organizations that are seeking to disrupt the status quo.

About ATED

ATED Therapeutics Ltd. Is an Israeli and U.S. based company dedicated to development of a diagnostic blood test as well as therapeutic drugs to treat Parkinson’s Disease which effects 14M people worldwide. We are seeking funding to apply to the FDA, and market the test.

About Yissum

Yissum is the technology transfer company of the Hebrew University of Jerusalem. Founded in 1964, Yissum serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry. Yissum’s mission is to benefit society by converting extraordinary innovations and transformational technologies into commercial solutions that address our most urgent global challenges. For further information please visit www.yissum.co.il

Contacts

Media: Jeff R. Swarz Ph.D., CEO (jswarz@mmdillon.com)

Contacts

Media: Jeff R. Swarz Ph.D., CEO (jswarz@mmdillon.com)